Cargando…

Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives

ABSTRACT: This article describes the synthesis and antimicrobial activity evaluation of new pipemidic acid derivatives. New compounds were obtained on the basis of Mannich reaction of 4,5-disubstituted 1,2,4-triazole-3-thiones with pipemidic acid. Antimicrobial tests revealed high antibacterial acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Popiołek, Łukasz, Biernasiuk, Anna, Paruch, Kinga, Malm, Anna, Wujec, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pharmaceutical Society of Korea 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028826/
https://www.ncbi.nlm.nih.gov/pubmed/29619676
http://dx.doi.org/10.1007/s12272-018-1025-3
_version_ 1783336847574827008
author Popiołek, Łukasz
Biernasiuk, Anna
Paruch, Kinga
Malm, Anna
Wujec, Monika
author_facet Popiołek, Łukasz
Biernasiuk, Anna
Paruch, Kinga
Malm, Anna
Wujec, Monika
author_sort Popiołek, Łukasz
collection PubMed
description ABSTRACT: This article describes the synthesis and antimicrobial activity evaluation of new pipemidic acid derivatives. New compounds were obtained on the basis of Mannich reaction of 4,5-disubstituted 1,2,4-triazole-3-thiones with pipemidic acid. Antimicrobial tests revealed high antibacterial activity of obtained derivatives. Gram-negative rods belonging to Enterobacteriaceae family were particularly most sensitive to new pipemidic acid derivatives. Synthesized compounds exhibited very strong activity towards Proteus mirabilis ATCC 12453, Salmonella typhimurium ATCC 14028 and Escherichia coli ATCC 25922. The minimum inhibitory concentrations of new pipemidic acid derivatives which inhibited the growth of these bacteria were 0.98–7.81 µg/ml, 0.98–7.81 µg/ml and 0.98–3.91 µg/ml, respectively. The antibacterial activity of newly synthesized pipemidic acid derivatives in many cases was far better than the activity of substances used as positive controls (nitrofurantoin, cefuroxime, ampicillin and pipemidic acid). GRAPHICAL ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12272-018-1025-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6028826
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Pharmaceutical Society of Korea
record_format MEDLINE/PubMed
spelling pubmed-60288262018-07-23 Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives Popiołek, Łukasz Biernasiuk, Anna Paruch, Kinga Malm, Anna Wujec, Monika Arch Pharm Res Research Article ABSTRACT: This article describes the synthesis and antimicrobial activity evaluation of new pipemidic acid derivatives. New compounds were obtained on the basis of Mannich reaction of 4,5-disubstituted 1,2,4-triazole-3-thiones with pipemidic acid. Antimicrobial tests revealed high antibacterial activity of obtained derivatives. Gram-negative rods belonging to Enterobacteriaceae family were particularly most sensitive to new pipemidic acid derivatives. Synthesized compounds exhibited very strong activity towards Proteus mirabilis ATCC 12453, Salmonella typhimurium ATCC 14028 and Escherichia coli ATCC 25922. The minimum inhibitory concentrations of new pipemidic acid derivatives which inhibited the growth of these bacteria were 0.98–7.81 µg/ml, 0.98–7.81 µg/ml and 0.98–3.91 µg/ml, respectively. The antibacterial activity of newly synthesized pipemidic acid derivatives in many cases was far better than the activity of substances used as positive controls (nitrofurantoin, cefuroxime, ampicillin and pipemidic acid). GRAPHICAL ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12272-018-1025-3) contains supplementary material, which is available to authorized users. Pharmaceutical Society of Korea 2018-04-04 2018 /pmc/articles/PMC6028826/ /pubmed/29619676 http://dx.doi.org/10.1007/s12272-018-1025-3 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research Article
Popiołek, Łukasz
Biernasiuk, Anna
Paruch, Kinga
Malm, Anna
Wujec, Monika
Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives
title Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives
title_full Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives
title_fullStr Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives
title_full_unstemmed Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives
title_short Synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives
title_sort synthesis and in vitro antimicrobial activity screening of new pipemidic acid derivatives
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028826/
https://www.ncbi.nlm.nih.gov/pubmed/29619676
http://dx.doi.org/10.1007/s12272-018-1025-3
work_keys_str_mv AT popiołekłukasz synthesisandinvitroantimicrobialactivityscreeningofnewpipemidicacidderivatives
AT biernasiukanna synthesisandinvitroantimicrobialactivityscreeningofnewpipemidicacidderivatives
AT paruchkinga synthesisandinvitroantimicrobialactivityscreeningofnewpipemidicacidderivatives
AT malmanna synthesisandinvitroantimicrobialactivityscreeningofnewpipemidicacidderivatives
AT wujecmonika synthesisandinvitroantimicrobialactivityscreeningofnewpipemidicacidderivatives